Laurus Labs Limited vs Neuland Laboratories Limited

A side-by-side comparison of Laurus Labs Limited (LAURUSLABS) and Neuland Laboratories Limited (NEULANDLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Neuland Laboratories Limited leads LAURUSLABS vs NEULANDLAB on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation04
  • Profitability04
  • Growth02
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

NEULANDLAB takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

125.08
P/E ratio
70.97
19.74
P/B ratio
16.30
0.10%
Dividend yield
0.14%
₹16.47
EPS
₹283.71

Profitability

NEULANDLAB takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.77%
Return on equity
19.42%
17.58%
Return on capital
23.57%
26.09%
EBITDA margin
28.40%
13.07%
Net margin
17.99%

Growth

NEULANDLAB takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

4.09%
Revenue CAGR (3Y)
19.31%
3.91%
Profit CAGR (3Y)
30.57%

Size & financial health

LAURUSLABS takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.11L Cr
Market cap
₹25,275 Cr
₹6,813 Cr
Revenue
₹2,023 Cr
₹890 Cr
Net profit
₹364 Cr
0.45
Debt / equity
0.16
Laurus Labs Limited
  • + []
  • − ["Stock is trading at 21.00 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
Neuland Laboratories Limited
  • + ["Company has delivered good profit growth of 35.1% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 22.1%", "Company has delivered good sales growth of 16.6% CAGR over last 5 years"]
  • − ["Stock is trading at 13.47 times its book value"]
Laurus Labs Limited full analysis Neuland Laboratories Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.